| 000 | 01285 a2200409 4500 | ||
|---|---|---|---|
| 005 | 20250513090340.0 | ||
| 264 | 0 | _c19960613 | |
| 008 | 199606s 0 0 eng d | ||
| 022 | _a0022-5347 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBittard, H | |
| 245 | 0 | 0 |
_aClinical evaluation of cell deoxyribonucleic acid content measured by flow cytometry in bladder cancer. _h[electronic resource] |
| 260 |
_bThe Journal of urology _cJun 1996 |
||
| 300 |
_a1887-91 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAneuploidy |
| 650 | 0 | 4 |
_aCarcinoma in Situ _xdiagnosis |
| 650 | 0 | 4 |
_aCarcinoma, Transitional Cell _xdiagnosis |
| 650 | 0 | 4 | _aCohort Studies |
| 650 | 0 | 4 |
_aDNA, Neoplasm _xanalysis |
| 650 | 0 | 4 | _aEvaluation Studies as Topic |
| 650 | 0 | 4 | _aFlow Cytometry |
| 650 | 0 | 4 | _aFollow-Up Studies |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aNeoplasm Staging |
| 650 | 0 | 4 | _aPloidies |
| 650 | 0 | 4 | _aPrognosis |
| 650 | 0 | 4 | _aProportional Hazards Models |
| 650 | 0 | 4 | _aSurvival Analysis |
| 650 | 0 | 4 | _aTime Factors |
| 650 | 0 | 4 |
_aUrinary Bladder _xpathology |
| 650 | 0 | 4 |
_aUrinary Bladder Neoplasms _xdiagnosis |
| 700 | 1 | _aLamy, B | |
| 700 | 1 | _aBillery, C | |
| 773 | 0 |
_tThe Journal of urology _gvol. 155 _gno. 6 _gp. 1887-91 |
|
| 999 |
_c8617325 _d8617325 |
||